Novel tools for drug repurposing in COL6 myopathies: accelerating the route towards therapy.

Awardee: Paolo Bonaldo

Institution: University of Padova, Department of Molecular Medicine

Award Amount: $42,406

Funding Period: February 1, 2021 - January 31, 2022

Previous
Previous

Targeting muscle stem cells for the treatment of Collagen VI muscular dystrophies

Next
Next

Global Registry for Inherited Neuropathies (GRIN) - Natural History Study Data Assessment of Charcot-Marie-Tooth (CMT) Patients (age 3-25) to Support Virtual Clinical Studies